ATE162798T1 - Entfernung von fettlöslichen reagenzien aus biologischen materialien durch extrahierung mit natürlichen ölen oder synthetischen ersätzen davon - Google Patents

Entfernung von fettlöslichen reagenzien aus biologischen materialien durch extrahierung mit natürlichen ölen oder synthetischen ersätzen davon

Info

Publication number
ATE162798T1
ATE162798T1 AT87103821T AT87103821T ATE162798T1 AT E162798 T1 ATE162798 T1 AT E162798T1 AT 87103821 T AT87103821 T AT 87103821T AT 87103821 T AT87103821 T AT 87103821T AT E162798 T1 ATE162798 T1 AT E162798T1
Authority
AT
Austria
Prior art keywords
biological materials
extraction
removal
phase
natural oils
Prior art date
Application number
AT87103821T
Other languages
English (en)
Inventor
Kenneth R Woods
Thomas W Orme
Original Assignee
New York Blood Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25297742&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE162798(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by New York Blood Center Inc filed Critical New York Blood Center Inc
Application granted granted Critical
Publication of ATE162798T1 publication Critical patent/ATE162798T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT87103821T 1986-03-31 1987-03-17 Entfernung von fettlöslichen reagenzien aus biologischen materialien durch extrahierung mit natürlichen ölen oder synthetischen ersätzen davon ATE162798T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/846,374 US4789545A (en) 1986-03-31 1986-03-31 Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof

Publications (1)

Publication Number Publication Date
ATE162798T1 true ATE162798T1 (de) 1998-02-15

Family

ID=25297742

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87103821T ATE162798T1 (de) 1986-03-31 1987-03-17 Entfernung von fettlöslichen reagenzien aus biologischen materialien durch extrahierung mit natürlichen ölen oder synthetischen ersätzen davon

Country Status (7)

Country Link
US (1) US4789545A (de)
EP (1) EP0239859B1 (de)
JP (2) JP2544619B2 (de)
AT (1) ATE162798T1 (de)
DE (1) DE3752165T2 (de)
ES (1) ES2112239T3 (de)
ZA (1) ZA87885B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128318A (en) * 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
US5338689A (en) * 1987-08-24 1994-08-16 Stiftung Fur Diagnostische Forschung Method and card for detecting antigens and/or antibodies
JPH087215B2 (ja) * 1987-08-24 1996-01-29 シュティフツング・フュア・ディアグノスティッシュ・フォルシュンク 抗原および／又は抗体の検出方法および検出用の試験キット
DE3730533A1 (de) * 1987-09-11 1989-03-30 Biotest Pharma Gmbh Verfahren zur sterilisation von plasma oder plasmafraktionen
US4909940A (en) * 1987-12-30 1990-03-20 New York Blood Center, Inc. Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons
ES2053619T3 (es) * 1988-05-27 1994-08-01 Centre Regional De Transfusion Procedimiento para la fabricacion de un factor antihemofilico de gran pureza y libre de virus mediante cromatografia.
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
DE3878245D1 (de) * 1988-11-05 1993-03-18 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
JP2782443B2 (ja) * 1988-12-26 1998-07-30 將純 吉原 抗エイズウィルス剤
US5026686A (en) * 1989-02-01 1991-06-25 Washington University Antiviral peptides
US4978688A (en) * 1989-03-24 1990-12-18 Louderback Allan Lee Method of treating white blood cells
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE4008852A1 (de) * 1990-03-20 1991-09-26 Octapharma Ag Verfahren zur herstellung von nicht-infektioesem blutplasma
DE4125625C2 (de) * 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
JPH06166634A (ja) * 1992-12-01 1994-06-14 Green Cross Corp:The プラスミノーゲン含有組成物の製造方法
SE9301582D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins
WO1995018665A1 (en) * 1994-01-10 1995-07-13 Hemasure, Inc. Device and process for removing leukocytes and viral inactivating agents from blood
US5639376A (en) * 1994-01-10 1997-06-17 Hemasure, Inc. Process for simultaneously removing leukocytes and methylene blue from plasma
US5486293A (en) * 1994-03-21 1996-01-23 Hemasure, Inc. Removal of small exogenous molecules from biological fluids
US6136865A (en) * 1995-05-20 2000-10-24 Octapharma Ag Method for reduction of the infectiousness of potentially infectious material
US5589072A (en) * 1995-07-26 1996-12-31 Shanbrom; Edward Trace capture in biological fluids
AU6021698A (en) * 1997-01-06 1998-08-03 Cerus Corporation Methods and devices for the reduction of small organic compounds from bloo d products
US7611831B2 (en) * 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
IL136552A (en) 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
JP4742042B2 (ja) * 2004-06-30 2011-08-10 テルモ株式会社 ウィルス不活化ヘモグロビンおよびその製造方法
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
EP1685852A1 (de) 2005-02-01 2006-08-02 Fondation pour la Recherche Diagnostique Set von Einwegbeuteln zur Virusinaktivierung von biologischen Fluids
CA2826969C (en) 2010-11-29 2019-02-19 New York Blood Center, Inc. Method of blood pooling and storage
IL210162A0 (en) 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
AU2013365623B2 (en) 2012-12-20 2017-08-24 Omrix Biopharmaceuticals Ltd. Viral inactivated biological mixture
RU2556804C2 (ru) * 2013-12-17 2015-07-20 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения РФ Способ получения концентрата фибриногена
WO2016123804A1 (en) 2015-02-06 2016-08-11 Guangzhou Bioseal Biotech Co., Ltd. Method for preparation of thrombin
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3647624A (en) * 1969-07-24 1972-03-07 Wisconsin Alumni Res Found Treatment of blood with oleaginous substance
US3682835A (en) * 1970-11-24 1972-08-08 Baxter Laboratories Inc Liquid blood serum control standard
FR2475572A1 (fr) * 1980-02-11 1981-08-14 Pasteur Institut Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications
DE3005495C2 (de) * 1980-02-14 1983-03-31 Institut Pasteur, 75724 Paris Herstellung von Fragmenten von Viren mit Lipidhülle und sie enthaltende Arzneimittelzubereitungen
JPS56127308A (en) * 1980-03-11 1981-10-06 Green Cross Corp:The Blood-coagulation factor 8 pharmaceutical
DE3173208D1 (en) * 1980-10-06 1986-01-23 Edward Shanbrom Method of reducing undesirable activities of biological and pharmaceutical products
US4314997A (en) * 1980-10-06 1982-02-09 Edward Shanbrom Purification of plasma protein products
SE441009B (sv) * 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4511556A (en) * 1982-06-10 1985-04-16 The United States Of America As Represented By The Department Of Health And Human Services Inactivation of a lipid virus
CA1208551A (en) * 1982-12-27 1986-07-29 Ricardo H. Landaburu Solvent treatment of plasma protein products
DE3310263A1 (de) * 1983-03-22 1984-09-27 Fresenius AG, 6380 Bad Homburg Verfahren zur entfernung von lipophilen stoffen aus waessrigen loesungen sowie vorrichtung zur durchfuehrung des verfahrens
US4534972A (en) * 1983-03-29 1985-08-13 Miles Laboratories, Inc. Protein compositions substantially free from infectious agents
EP0124363B1 (de) * 1983-05-02 1990-12-19 Diamond Scientific Co. Photochemische Entkeimungsbehandlung von vollem Blut oder Blutbestandteilen
AT376881B (de) * 1983-05-02 1985-01-10 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen krankheitserregern
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4615886A (en) * 1983-08-31 1986-10-07 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus
US4490361A (en) * 1983-12-02 1984-12-25 Alpha Therapeutic Corporation Virus inactivating heat treatment of plasma fractions

Also Published As

Publication number Publication date
JPH08268898A (ja) 1996-10-15
DE3752165D1 (de) 1998-03-05
JP2544619B2 (ja) 1996-10-16
EP0239859A2 (de) 1987-10-07
US4789545A (en) 1988-12-06
EP0239859A3 (de) 1988-06-22
JPS62240623A (ja) 1987-10-21
EP0239859B1 (de) 1998-01-28
ES2112239T3 (es) 1998-04-01
ZA87885B (en) 1987-09-30
DE3752165T2 (de) 1998-06-25

Similar Documents

Publication Publication Date Title
ATE162798T1 (de) Entfernung von fettlöslichen reagenzien aus biologischen materialien durch extrahierung mit natürlichen ölen oder synthetischen ersätzen davon
ATE88093T1 (de) Ausscheidung von prozesschemikalien aus biologischen gemischen mit halogenierten kohlenwasserstoffen.
DE3767077D1 (de) Verfahren zur abtrennung von cholesterin aus fettsubstanzen tierischen ursprungs und cholesterinarme fettsubstanzen.
DE3772307D1 (de) Verfahren zur reinigung von propandiol-1,3.
DE3764011D1 (de) Verfahren und vorrichtung zur ultraschallextraktion von oelhaltigen stoffen aus oelhaltigen saaten.
DE3485446D1 (de) Vorrichtung und verfahren zur erzeugung bzw. freisetzung und abtrennung von substanzen oder partikulaeren gebilden aus fluessiger, plastischer oder fester materie und verwendung der vorrichtung.
ATE76057T1 (de) Verfahren zur herstellung von reinen monoglyceriden und reinen diglyceriden aus einem gemisch, das mono-, di- und triglyceride enthaelt.
ATE51606T1 (de) Verfahren und vorrichtung zum entschlammen von gewaessern.
DE3765158D1 (de) Verfahren zur abtrennung von phenolen und basen aus steinkohlenteeroelen durch extraktion.
ATE78290T1 (de) Verfahren zur behandlung einer kontaminierten emulsion.
US4378229A (en) Method for treating sewage to produce a fuel
DE69921778D1 (de) Verfahren zur herstellung von isoflavonverbindungen
DE68900939D1 (de) Entfernung von sauren verunreinigungen in einem loesungsmittelextraktionsverfahren zur trennung von aromaten von nichtaromaten.
ATE42965T1 (de) Verfahren zur herstellung von stabilen ozonisierten oelen aus ungesaettigten pflanzenoelen.
ATE90662T1 (de) Verfahren zur trennung eines gemisches aus 1methoxypropanol-2 und wasser in seine bestandteile.
DE3876168D1 (de) Verfahren zur behandlung und entsorgung von gemengen aus feststoffen und fluessigkeiten.
DE3867019D1 (de) Verfahren zur herstellung eines propolis-aethanolextraktes.
DE69105988D1 (de) Extrahiere von cholesterin aus eigelb.
DE3780087D1 (de) Verfahren zum behandeln von kaffee.
SU956432A1 (ru) Способ извлечени щавелевой кислоты из жидкостей
DE3883732D1 (de) Aufbereitungsverfahren für Leinsamen.
ATE12250T1 (de) Verfahren zur herstellung eines oelartigen stoffgemisches aus flachs.
MY118762A (en) Water treatment method and water treatment agent used therefor
DE3774540D1 (de) Verfahren zum raffinieren von fett.
DE69005781D1 (de) Verfahren zur Trennung von Verunreinigungen aus dem Boden.